Own, control, and monetize your RNA data in a decentralized, ethical marketplace. Powered by blockchain, protected by smart contracts, and driven by you.
Own your data. Control who sees it.
Smart contracts fund RNA. Everyone shares the value.
At LifeOME AI, we empower individuals to own and control their RNA data through a decentralized system. When users sequence their RNA, the data is minted as an Ownership NFT, making them the rightful digital owner.
They can create Access Tokens to securely share their data for analysis, research, or commercial use. For example, Alice can grant LifeOME AI access to her data and later reclaim the token.
Users can also mint and resell tokens, enabling brokers to distribute data to pharma or AI firms. This model ensures ethical control, fair value, and transparency, redefining RNA as a user-owned digital asset.
Your RNA data is minted as an NFT you own and control. You decide who accesses it and how it’s monetized.
LifeOME AI puts your data back in your hands—secure, private, and user-owned.
Create Access Tokens for limited, trackable data sharing. Each token represents a specific use case.
You decide how many tokens to issue and to whom—making your data a flexible asset.
Share a token with LifeOME AI to get a detailed RNA analysis report. The token remains yours to reclaim.
Get insights while keeping control—use your data without giving it away.
Pharma and AI companies access RNA data by acquiring tokens with your consent. Brokers facilitate ethical resale.
Data owners benefit, not just corporations.
RNA Ownership
RNA sequencing data is converted into secure NFTs, giving users full digital ownership and control.
AI-Powered Insights
Access Tokens allow LifeOME AI to analyze data and deliver personalized reports with actionable results.
Marketplace Integration
Users can share or resell data access through brokers or connect directly with industry partners.
RNA Test Sponsorship enables brokers or end customers to support individuals’ RNA sequencing by purchasing testing credits and compensation packages in advance. In return, they receive access to ethically sourced, high-quality RNA data.
This process is governed by smart contracts that ensure transparency, consent, and traceability at every step. Data owners like Alice are fairly compensated and remain in control, while sponsors gain legitimate access to data they can trust.
- Broker Purchase: Brokers buy LOCs, PUCs, and Vouchers in bulk to sponsor tests.
- Data Contributor Compensation: Alice receives prepaid coupons as reward for sharing her RNA data.
- NFT Minting: Her RNA data is turned into an Ownership NFT—secure and user-owned.
- Access Token Issued: LifeOME AI receives an Access Token to analyze the data.
- Token Buyback: Broker pays Alice so she can reclaim and transfer the token.
The RNA Test Sponsorship model ensures that data contributors like Alice are fairly compensated before their data is used. They retain ownership, with full visibility into how and by whom their data is accessed.
For brokers and companies, it offers secure, permissioned access to high-quality RNA data via tokenized smart contracts—making the system both scalable and ethically compliant.
LifeOME AI operates on a multi-path revenue model that supports sustainable genomics research and ethical data sharing.
From selling tokenized packages to enabling secure access to RNA data, each stream is designed to balance profitability with individual data control.
